Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential.
about
The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinomaMatrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2: BINDING STUDIES AND CRYSTAL STRUCTUREMatrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP ComplexesThe impact of the Cancer Genome Atlas on lung cancer.Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung AdenocarcinomaTumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changesCD271 defines a stem cell-like population in hypopharyngeal cancer.Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cellsTranscriptome study and identification of potential marker genes related to the stable expression of recombinant proteins in CHO clones.Immunological effects and therapeutic role of C5a in cancer.FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.Matrix metalloproteinase-10 regulates stemness of ovarian cancer stem-like cells by activation of canonical Wnt signaling and can be a target of chemotherapy-resistant ovarian cancer.Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes.PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis.Characterization of a P-Rex1 gene signature in breast cancer cellsRole of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia.Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.Targeting oncogenic protein kinase Cι for treatment of mutant KRAS LADC.Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell lineMolecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.Understanding Lunasin's biology and potential as a cancer therapeutic by utilizing Drosophila genetics.Stemness and plasticity of lung cancer cells: paving the road for better therapy.A bayesian integrative model for genetical genomics with spatially informed variable selection.Probenecid Sensitizes Neuroblastoma Cancer Stem Cells to Cisplatin.Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells.Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties.Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis.Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.Utility and applications of orthotopic models of human non-small cell lung cancer (NSCLC) for the evaluation of novel and emerging cancer therapeutics.A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer.Reactive oxygen species-mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression.Comparison of tumor biology of two distinct cell sub-populations in lung cancer stem cells.The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade.Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases.Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy.H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression
P2860
Q24337113-5C2DB01E-91F7-4290-9DFB-452071167654Q27678085-00D2B636-AB64-4935-80F5-D145BEF12910Q27680082-9C7CAFD7-5E62-47C8-99B4-E6E021068511Q28084190-6C6893D4-4A8D-4657-A526-6A0D847AD332Q28115044-8F193C0B-7AA1-43B2-991A-C4E17331A484Q28539958-BCC09974-2BE7-4867-973E-4359619C0F37Q34692612-C6E4A0D1-B414-4BAE-8376-5AE28E7812A6Q35238399-D75E2590-CE5B-469B-8A19-8DCCED9FFC1CQ35820624-29D4A6B9-6343-43A7-B55C-06EE5D19F0D8Q36260122-A14C34F5-CD7E-4897-A0B2-B75B10FAFE9BQ37046814-47466857-1214-4CE3-9FC6-B3983CE8A538Q37295807-80A507D5-AED5-4082-8410-57544AA8EFFDQ37459618-DB961C41-2482-4547-878A-460EB42EF33AQ37466903-816D9E89-12C2-4253-9277-BB65D4F26B49Q37588287-0F876DDA-F585-473B-911D-8F0B889D56EDQ37641550-50AB368B-C41D-40DD-963A-57DFE316E5C9Q37651549-08E237E8-4CC9-476A-A463-4D28AE755959Q37673912-1D586F4F-19FD-4CF1-97D7-709E9615EF1BQ37717845-6CC42261-D0E1-486E-9373-CF3D0F93AAA8Q38093654-98BFD7DE-B9AA-4249-809D-E92DAB1EFB64Q38195673-209F627D-1771-49DA-B182-AEC1BF801387Q38229007-7F0B0664-F6AE-451A-9F5C-5F4C97CE35E4Q38471824-A0B764EA-59ED-4DAE-A0DB-36CE59966AC1Q38787387-ED9CE379-BE10-451D-BA9C-FF099A9E6134Q38830254-27FB1542-052A-4FC6-9A10-54528A78CF4DQ38852605-9311F9BD-0F64-4BCA-A083-F43FDBB2299DQ38895324-56E136E3-F658-40BC-87F7-486D7E10FF1BQ38925880-C9501609-00F2-4AA7-9AF7-0E02955CF870Q39025641-FE5340C5-C88F-46C3-8CCB-B9E364B67DACQ39069356-42397C3C-5A1B-483B-8410-2BBB842DC71CQ41489569-908D6E89-4202-48C8-9C75-7F99B15DFEB3Q47106862-D0CE0B8B-9E33-4F99-8154-7787013C7BDAQ47794460-64DE4798-EE9E-4CEB-A2EB-2388E159036BQ50027179-0F0084A3-7D13-40D9-B2D2-D565781C9B8BQ50053859-3B11EFF3-7247-4A2A-9665-11951596CCB9Q51155840-9ADCBE44-2512-4101-ADF2-4ECA86AD5755Q52731749-B30BA6C8-59B9-4C22-A07C-51F45B6EA042Q59134782-991927EB-A648-41D3-9588-06343DB0FC28
P2860
Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Matrix metalloproteinase-10 is ...... tion and metastatic potential.
@ast
Matrix metalloproteinase-10 is ...... tion and metastatic potential.
@en
Matrix metalloproteinase-10 is ...... tion and metastatic potential.
@nl
type
label
Matrix metalloproteinase-10 is ...... tion and metastatic potential.
@ast
Matrix metalloproteinase-10 is ...... tion and metastatic potential.
@en
Matrix metalloproteinase-10 is ...... tion and metastatic potential.
@nl
prefLabel
Matrix metalloproteinase-10 is ...... tion and metastatic potential.
@ast
Matrix metalloproteinase-10 is ...... tion and metastatic potential.
@en
Matrix metalloproteinase-10 is ...... tion and metastatic potential.
@nl
P2093
P2860
P1433
P1476
Matrix metalloproteinase-10 is ...... tion and metastatic potential.
@en
P2093
Alan P Fields
I-Chu Tseng
Jyotica Batra
Michael P Walsh
Nicole R Murray
Roderick P Regala
Verline Justilien
P2860
P304
P356
10.1371/JOURNAL.PONE.0035040
P407
P577
2012-04-24T00:00:00Z